Cellebrite Stock Options
| CLBT Stock | USD 18.78 0.28 1.51% |
Cellebrite's latest option contracts expiring on November 21st 2025 are carrying combined implied volatility of 0.9 with a put-to-call open interest ratio of 0.64 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on November 21st 2025. The total put volume is at 125, with calls trading at the volume of 245. This yields a 0.51 put-to-call volume ratio.
Open Interest Against November 21st 2025 Option Contracts
Cellebrite option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Cellebrite's lending market. For example, when Cellebrite's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Cellebrite, he or she must hedge the risk by shorting Cellebrite stock over its option's life.
2025-11-21
The chart above shows Cellebrite's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Cellebrite's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Cellebrite's option, there is no secondary market available for investors to trade.
Cellebrite Maximum Pain Price Across 2025-11-21 Option Contracts
Max pain occurs when Cellebrite's market makers reach a net positive position across all Cellebrite's options at a strike price where option holders stand to lose the most money. By contrast, Cellebrite's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Cellebrite
Analyzing Cellebrite's in-the-money options over time can help investors to take a profitable long position in Cellebrite regardless of its overall volatility. This is especially true when Cellebrite's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Cellebrite's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Cellebrite's stock while costing only a fraction of its price.
Cellebrite DI In The Money Call Balance
When Cellebrite's strike price is surpassing the current stock price, the option contract against Cellebrite DI stock is said to be in the money. When it comes to buying Cellebrite's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Cellebrite DI are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Cellebrite Current Options Market Mood
Cellebrite's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Cellebrite Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Using current Cellebrite's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Cellebrite contract
Base on the Rule 16, the options market is currently suggesting that Cellebrite DI will have an average daily up or down price movement of about 0.0563% per day over the life of the 2025-11-21 option contract. With Cellebrite trading at USD 18.78, that is roughly USD 0.0106. If you think that the market is fully incorporating Cellebrite's daily price movement you should consider buying Cellebrite DI options at the current volatility level of 0.9%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Cellebrite | Build AI portfolio with Cellebrite Stock |
Purchasing Cellebrite options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Cellebrite calls. Remember, the seller must deliver Cellebrite DI stock to the call owner when a call is exercised.
Cellebrite Option Chain
When Cellebrite's strike price is surpassing the current stock price, the option contract against Cellebrite DI stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Cellebrite's option chain is a display of a range of information that helps investors for ways to trade options on Cellebrite. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Cellebrite. It also shows strike prices and maturity days for a Cellebrite against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | CLBT251121C00035000 | 1 | 35.0 | 0.0 - 0.75 | 0.05 | Out |
Call | CLBT251121C00030000 | 0 | 30.0 | 0.0 - 0.75 | 0.75 | |
Call | CLBT251121C00025000 | 20 | 25.0 | 0.0 - 0.2 | 0.25 | Out |
Call | CLBT251121C00022500 | 0 | 22.5 | 0.0 - 0.4 | 0.39 | |
Call | CLBT251121C00020000 | 118 | 20.0 | 0.75 - 0.95 | 0.83 | Out |
Call | CLBT251121C00017500 | 41 | 17.5 | 1.65 - 2.2 | 1.99 | In |
Call | CLBT251121C00015000 | 3 | 15.0 | 3.6 - 4.0 | 4.29 | In |
Call | CLBT251121C00012500 | 0 | 12.5 | 5.7 - 7.3 | 5.7 | In |
Call | CLBT251121C00010000 | 0 | 10.0 | 8.5 - 10.3 | 8.5 | In |
Call | CLBT251121C00007500 | 0 | 7.5 | 10.1 - 12.9 | 10.1 | In |
Put | CLBT251121P00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Put | CLBT251121P00010000 | 0 | 10.0 | 0.0 - 0.75 | 0.75 | |
Put | CLBT251121P00012500 | 0 | 12.5 | 0.0 - 0.75 | 0.75 | |
Put | CLBT251121P00015000 | 21 | 15.0 | 0.15 - 0.3 | 0.25 | Out |
Put | CLBT251121P00017500 | 76 | 17.5 | 0.0 - 1.0 | 0.8 | Out |
Put | CLBT251121P00020000 | 21 | 20.0 | 2.1 - 2.3 | 2.45 | In |
Put | CLBT251121P00022500 | 0 | 22.5 | 4.1 - 4.3 | 4.1 | In |
Put | CLBT251121P00025000 | 0 | 25.0 | 6.1 - 7.1 | 6.1 | In |
Put | CLBT251121P00030000 | 0 | 30.0 | 11.1 - 11.8 | 11.1 | In |
Put | CLBT251121P00035000 | 0 | 35.0 | 16.1 - 16.9 | 16.1 | In |
Cellebrite Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Cellebrite Total Stockholder Equity
Total Stockholder Equity |
|
Cellebrite Corporate Management
| Yossi Carmil | CEO Founder | Profile | |
| Zohar TadmorEilat | Chief Officer | Profile | |
| Sigalit Shavit | Chief Officer | Profile | |
| Osnat Tirosh | Chief Officer | Profile | |
| David Gee | Chief Officer | Profile | |
| Adam Jaffe | VP Communications | Profile |
Additional Tools for Cellebrite Stock Analysis
When running Cellebrite's price analysis, check to measure Cellebrite's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellebrite is operating at the current time. Most of Cellebrite's value examination focuses on studying past and present price action to predict the probability of Cellebrite's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellebrite's price. Additionally, you may evaluate how the addition of Cellebrite to your portfolios can decrease your overall portfolio volatility.